A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study

Ana Jessica Pinto, Tiago Peçanha, Kamila Meireles, Fabiana Braga Benatti, Karina Bonfiglioli, Ana Lúcia de Sá Pinto, Fernanda Rodrigues Lima, Rosa Maria Rodrigues Pereira, Maria Claudia Costa Irigoyen, James Turner, John P Kirwan, Neville Owen, David W Dunstan, Hamilton Roschel, Bruno Gualano

Research output: Contribution to journalArticle

Abstract

Background: Rheumatoid arthritis patients spend most of their daily hours in sedentary behaviors (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis.

Methods: The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal rheumatoid arthritis patients will set individually-tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow-up. Outcomes will include: objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches.

Discussion: Findings will be of scientific and clinical relevance, with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in rheumatoid arthritis patients.

Trial registration: ClinicalTrials.gov identifier: NCT03186924; registered on 14 June 2017 (https://clinicaltrials.gov/ct2/show/NCT03186924).
Original languageEnglish
JournalTrials
Publication statusAccepted/In press - 21 Jan 2020

Cite this

Pinto, A. J., Peçanha, T., Meireles, K., Benatti, F. B., Bonfiglioli, K., Lúcia de Sá Pinto, A., ... Gualano, B. (Accepted/In press). A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study. Trials.

A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study. / Pinto, Ana Jessica ; Peçanha, Tiago; Meireles, Kamila; Benatti, Fabiana Braga; Bonfiglioli, Karina; Lúcia de Sá Pinto, Ana; Lima, Fernanda Rodrigues ; Pereira, Rosa Maria Rodrigues ; Irigoyen, Maria Claudia Costa; Turner, James; Kirwan, John P; Owen, Neville; Dunstan, David W; Roschel, Hamilton; Gualano, Bruno.

In: Trials, 21.01.2020.

Research output: Contribution to journalArticle

Pinto, AJ, Peçanha, T, Meireles, K, Benatti, FB, Bonfiglioli, K, Lúcia de Sá Pinto, A, Lima, FR, Pereira, RMR, Irigoyen, MCC, Turner, J, Kirwan, JP, Owen, N, Dunstan, DW, Roschel, H & Gualano, B 2020, 'A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study', Trials.
Pinto AJ, Peçanha T, Meireles K, Benatti FB, Bonfiglioli K, Lúcia de Sá Pinto A et al. A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study. Trials. 2020 Jan 21.
Pinto, Ana Jessica ; Peçanha, Tiago ; Meireles, Kamila ; Benatti, Fabiana Braga ; Bonfiglioli, Karina ; Lúcia de Sá Pinto, Ana ; Lima, Fernanda Rodrigues ; Pereira, Rosa Maria Rodrigues ; Irigoyen, Maria Claudia Costa ; Turner, James ; Kirwan, John P ; Owen, Neville ; Dunstan, David W ; Roschel, Hamilton ; Gualano, Bruno. / A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study. In: Trials. 2020.
@article{edee64b73a0a4590a565dd410e1d342b,
title = "A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study",
abstract = "Background: Rheumatoid arthritis patients spend most of their daily hours in sedentary behaviors (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis.Methods: The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal rheumatoid arthritis patients will set individually-tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow-up. Outcomes will include: objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches.Discussion: Findings will be of scientific and clinical relevance, with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in rheumatoid arthritis patients. Trial registration: ClinicalTrials.gov identifier: NCT03186924; registered on 14 June 2017 (https://clinicaltrials.gov/ct2/show/NCT03186924).",
author = "Pinto, {Ana Jessica} and Tiago Pe{\cc}anha and Kamila Meireles and Benatti, {Fabiana Braga} and Karina Bonfiglioli and {L{\'u}cia de S{\'a} Pinto}, Ana and Lima, {Fernanda Rodrigues} and Pereira, {Rosa Maria Rodrigues} and Irigoyen, {Maria Claudia Costa} and James Turner and Kirwan, {John P} and Neville Owen and Dunstan, {David W} and Hamilton Roschel and Bruno Gualano",
year = "2020",
month = "1",
day = "21",
language = "English",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",

}

TY - JOUR

T1 - A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: Protocol and rationale of the Take a STAND for Health study

AU - Pinto, Ana Jessica

AU - Peçanha, Tiago

AU - Meireles, Kamila

AU - Benatti, Fabiana Braga

AU - Bonfiglioli, Karina

AU - Lúcia de Sá Pinto, Ana

AU - Lima, Fernanda Rodrigues

AU - Pereira, Rosa Maria Rodrigues

AU - Irigoyen, Maria Claudia Costa

AU - Turner, James

AU - Kirwan, John P

AU - Owen, Neville

AU - Dunstan, David W

AU - Roschel, Hamilton

AU - Gualano, Bruno

PY - 2020/1/21

Y1 - 2020/1/21

N2 - Background: Rheumatoid arthritis patients spend most of their daily hours in sedentary behaviors (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis.Methods: The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal rheumatoid arthritis patients will set individually-tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow-up. Outcomes will include: objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches.Discussion: Findings will be of scientific and clinical relevance, with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in rheumatoid arthritis patients. Trial registration: ClinicalTrials.gov identifier: NCT03186924; registered on 14 June 2017 (https://clinicaltrials.gov/ct2/show/NCT03186924).

AB - Background: Rheumatoid arthritis patients spend most of their daily hours in sedentary behaviors (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis.Methods: The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal rheumatoid arthritis patients will set individually-tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow-up. Outcomes will include: objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches.Discussion: Findings will be of scientific and clinical relevance, with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in rheumatoid arthritis patients. Trial registration: ClinicalTrials.gov identifier: NCT03186924; registered on 14 June 2017 (https://clinicaltrials.gov/ct2/show/NCT03186924).

M3 - Article

JO - Trials

JF - Trials

SN - 1745-6215

ER -